OZABIO at Vitafoods Asia 2025: Showcasing the Future of Nutraceutical Innovation

OZABIO proudly participated in Vitafoods Asia 2025, one of the region’s most influential platforms for nutraceuticals and functional ingredients. The event brought together industry leaders, innovators, and forward-thinking brands, creating a dynamic space to explore the future of health and nutrition.

At the exhibition, OZABIO showcased its advanced LIPOZA liposomal technology, highlighting how next-generation delivery systems are transforming ingredient performance through enhanced bioavailability, stability, and targeted nutrient delivery. Our presence reflected our commitment to driving science-backed innovation and delivering solutions that go beyond conventional formulations.

Our Experience & Key Highlights

Participating in Vitafoods Asia 2025 provided OZABIO with a valuable opportunity to:

● Connect with global partners, manufacturers, and nutraceutical brands
● Present our cutting-edge liposomal solutions to a wider audience
● Engage in meaningful discussions around emerging trends, regulatory developments, and market demands

The event reinforced OZABIO’s position as a trusted innovation partner, focused on enabling brands to create high-performance, differentiated products.

Driving Innovation Beyond the Event

Our participation at Vitafoods Asia reflects OZABIO’s ongoing mission to advance nutraceutical science and strengthen global collaborations. Events like these allow us to stay at the forefront of industry evolution while continuously refining our technologies to meet the changing needs of the market.

Get In Touch

Phone: +91 78769 66742, +1 (571)315-3939, +971 52 156 2603

Mail: [email protected]

Location: 1207 Delaware Ave #2877, Wilmington DE 19806, USA

© 2026 OzaBio | All Rights Reserved.

Dynamic Light Scattering (DLS) for particle size measurement

Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin

Zeta Potential Analysis for surface charge and stability

Zeta potential analysis provides insight into the surface charge and colloidal stability of liposomal formulations, where higher negative values indicate improved dispersion stability and reduced risk of particle aggregation.
For example – Lipoza®-VitC

Absorption and permeability through models like Caco-2 cell lines.

Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.

For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.

1.TEM-Based Structural Analysis of Liposomal Formulations

Transmission Electron Microscopy (TEM) provides high-resolution visualization of liposomal morphology, enabling assessment of vesicle size, shape, and internal structure. Liposomes generally appear as well-defined spherical vesicles with a distinct bilayer and a darker core region.
For example – Lipoza®-Q10

2.SEM-Based Surface Characterization of Liposomes

Scanning Electron Microscopy (SEM) offers detailed visualization of surface morphology, enabling assessment of particle texture, external structure, and overall physical characteristics of liposomal powders. This technique helps confirm uniformity, surface smoothness, and morphological integrity of the formulation.
For example – Lipoza®-Fe
ozabio
Contact Form

Contact Information

Fill out the form below and we'll get back to you soon

Form submitted successfully! We'll contact you soon.
There was an error submitting the form. Please try again.

* indicates required question